GENEVA, July 31 -- DYNE THERAPEUTICS, INC. filed a patent application (US2026/012241) for “TRANSFERRIN RECEPTOR-TARGETING AGENTS AND GCN2 INHIBITORS”. With publication no. WO/2026/161628, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....